These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 38589468
1. A dual-targeting antifungal is effective against multidrug-resistant human fungal pathogens. Zhou M, Liu L, Cong Z, Jiang W, Xiao X, Xie J, Luo Z, Chen S, Wu Y, Xue X, Shao N, Liu R. Nat Microbiol; 2024 May; 9(5):1325-1339. PubMed ID: 38589468 [Abstract] [Full Text] [Related]
6. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D. Med Mycol; 1998 May; 36 Suppl 1():119-28. PubMed ID: 9988500 [Abstract] [Full Text] [Related]
8. The limitless endophytes: their role as antifungal agents against top priority pathogens. Moussa AY. Microb Cell Fact; 2024 May 31; 23(1):161. PubMed ID: 38822407 [Abstract] [Full Text] [Related]
9. In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum. Tsuchimori N, Hayashi R, Kitamoto N, Asai K, Kitazaki T, Iizawa Y, Itoh K, Okonogi K. Antimicrob Agents Chemother; 2002 May 31; 46(5):1388-93. PubMed ID: 11959573 [Abstract] [Full Text] [Related]
10. Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species. Chitty JL, Butler MS, Suboh A, Edwards DJ, Cooper MA, Fraser JA, Robertson AAB. Antimicrob Agents Chemother; 2018 Feb 31; 62(2):. PubMed ID: 29158283 [Abstract] [Full Text] [Related]
12. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN. Diagn Microbiol Infect Dis; 2011 Jan 31; 69(1):45-50. PubMed ID: 21146713 [Abstract] [Full Text] [Related]
13. Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy. Ambati S, Ferarro AR, Kang SE, Lin J, Lin X, Momany M, Lewis ZA, Meagher RB. mSphere; 2019 Feb 13; 4(1):. PubMed ID: 30760610 [Abstract] [Full Text] [Related]
14. Regulation of multidrug resistance in pathogenic fungi. Morschhäuser J. Fungal Genet Biol; 2010 Feb 13; 47(2):94-106. PubMed ID: 19665571 [Abstract] [Full Text] [Related]
15. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens. Uchida K, Nishiyama Y, Yokota N, Yamaguchi H. J Antibiot (Tokyo); 2000 Oct 13; 53(10):1175-81. PubMed ID: 11132964 [Abstract] [Full Text] [Related]
16. A chemical screen identifies structurally diverse metal chelators with activity against the fungal pathogen Candida albicans. Fallah S, Duncan D, Reichl KD, Smith MJ, Wang W, Porco JA, Brown LE, Whitesell L, Robbins N, Cowen LE. Microbiol Spectr; 2024 Apr 02; 12(4):e0409523. PubMed ID: 38376363 [Abstract] [Full Text] [Related]
17. Activity of contemporary antifungal agents, including the novel echinocandin anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007). Messer SA, Moet GJ, Kirby JT, Jones RN. J Clin Microbiol; 2009 Jun 02; 47(6):1942-6. PubMed ID: 19386851 [Abstract] [Full Text] [Related]